Arnold L Oronsky - Net Worth and Insider Trading

Arnold L Oronsky Net Worth

The estimated net worth of Arnold L Oronsky is at least $16 Million dollars as of 2024-11-05. Arnold L Oronsky is the Director, 10% Owner of PMV Pharmaceuticals Inc and owns about 6,469,356 shares of PMV Pharmaceuticals Inc (PMVP) stock worth over $11 Million. Arnold L Oronsky is the Director of KalVista Pharmaceuticals Inc and owns about 388,766 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $4 Million. Arnold L Oronsky is also the Director of Dynavax Technologies Corp and owns about 37,506 shares of Dynavax Technologies Corp (DVAX) stock worth over $448,759. Besides these, Arnold L Oronsky also holds Tesaro Inc (TSRO) . Details can be seen in Arnold L Oronsky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arnold L Oronsky has not made any transactions after 2020-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Arnold L Oronsky

Arnold L Oronsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arnold L Oronsky owns 17 companies in total, including KalVista Pharmaceuticals Inc (KALV) , PMV Pharmaceuticals Inc (PMVP) , and Dynavax Technologies Corp (DVAX) among others .

Click here to see the complete history of Arnold L Oronsky’s form 4 insider trades.

Insider Ownership Summary of Arnold L Oronsky

Ticker	Comapny	Transaction Date	Type of Owner
KALV	KalVista Pharmaceuticals Inc	2018-09-10	director
PMVP	PMV Pharmaceuticals Inc	2020-09-25	director & 10 percent owner
DVAX	Dynavax Technologies Corp	2013-10-30	director
		2019-11-21	10 percent owner
		2019-08-20	10 percent owner
		2019-08-06	10 percent owner
		2018-10-18	10 percent owner
		2018-08-07	director
		2015-11-19	director
		2015-06-24	10 percent owner
		2015-06-18	10 percent owner
		2014-05-29	10 percent owner
		2013-10-09	director & 10 percent owner
		2011-09-20	10 percent owner
		2009-06-23	director
		2007-11-20	10 percent owner
		2018-08-23	10 percent owner

Arnold L Oronsky Latest Holdings Summary

Arnold L Oronsky currently owns a total of 4 stocks. Among these stocks, Arnold L Oronsky owns 6,469,356 shares of PMV Pharmaceuticals Inc (PMVP) as of September 25, 2020, with a value of $11 Million and a weighting of 68.15%. Arnold L Oronsky owns 388,766 shares of KalVista Pharmaceuticals Inc (KALV) as of September 10, 2018, with a value of $4 Million and a weighting of 27.81%. Arnold L Oronsky also owns 37,506 shares of Dynavax Technologies Corp (DVAX) as of October 30, 2013, with a value of $448,759 and a weighting of 2.86%. The other 1 stocks Tesaro Inc (TSRO) have a combined weighting of 1.18% among all his current holdings.

Latest Holdings of Arnold L Oronsky

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PMVP	PMV Pharmaceuticals Inc	2020-09-25	6,469,356	1.66	10,706,784
KALV	KalVista Pharmaceuticals Inc	2018-09-10	388,766	11.24	4,369,730
DVAX	Dynavax Technologies Corp	2013-10-30	37,506	11.97	448,759
TSRO	Tesaro Inc	2018-08-07	2,479	74.96	185,826

Holding Weightings of Arnold L Oronsky

Arnold L Oronsky Form 4 Trading Tracker

According to the SEC Form 4 filings, Arnold L Oronsky has made a total of 2 transactions in PMV Pharmaceuticals Inc (PMVP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in PMV Pharmaceuticals Inc is the acquisition of 55,000 shares on September 25, 2020, which cost Arnold L Oronsky around $990,000.

According to the SEC Form 4 filings, Arnold L Oronsky has made a total of 0 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years. The most-recent trade in KalVista Pharmaceuticals Inc is the acquisition of 58,824 shares on September 10, 2018, which cost Arnold L Oronsky around $1 Million.

According to the SEC Form 4 filings, Arnold L Oronsky has made a total of 0 transactions in Dynavax Technologies Corp (DVAX) over the past 5 years. The most-recent trade in Dynavax Technologies Corp is the acquisition of 18,605 shares on October 30, 2013, which cost Arnold L Oronsky around $200,931.

More details on Arnold L Oronsky's insider transactions can be found in the Insider Trading History of Arnold L Oronsky table.

Insider Trading History of Arnold L Oronsky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arnold L Oronsky Trading Performance

GuruFocus tracks the stock performance after each of Arnold L Oronsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arnold L Oronsky is 31.96%. GuruFocus also compares Arnold L Oronsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arnold L Oronsky within 3 months outperforms 6 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Arnold L Oronsky's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Arnold L Oronsky

Average Return

Average return per transaction

Outperforming Transactions

4 out of 7 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.36
Relative Return to S&P 500(%)	2

Arnold L Oronsky Ownership Network

Ownership Network List of Arnold L Oronsky

No Data

Ownership Network Relation of Arnold L Oronsky

Arnold L Oronsky Owned Company Details

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Arnold L Oronsky is the director of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .

In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

What does PMV Pharmaceuticals Inc do?

Who are the key executives at PMV Pharmaceuticals Inc?

Arnold L Oronsky is the director & 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .

PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 11,322 shares made by Deepika Jalota , a net sale of 87,786 shares made by Orbimed Advisors Llc , and a net sale of 6,291 shares made by Leila Alland .

In summary, during the past 3 months, insiders sold 10,109 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 10,109 shares. During the past 18 months, 108,290 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,290 shares.

PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.

PMV Pharmaceuticals Inc Insider Transactions

No Available Data

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Arnold L Oronsky is the director of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 3,000,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,247,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,247,529 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dynavax Technologies Corp Insider Transactions

No Available Data

What does Avedro Inc do?

Who are the key executives at Avedro Inc?

Arnold L Oronsky is the 10 percent owner of Avedro Inc. Other key executives at Avedro Inc include 10 percent owner Gilbert H Kliman , General Counsel and Sec. Paul S Bavier , and director & President and CEO Reza Zadno .

Avedro Inc (AVDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Avedro Inc (AVDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avedro Inc (AVDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Avedro Inc (AVDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avedro Inc Insider Transactions

No Available Data

What does Venus Concept Inc do?

Who are the key executives at Venus Concept Inc?

Arnold L Oronsky is the 10 percent owner of Venus Concept Inc. Other key executives at Venus Concept Inc include 10 percent owner Michael Willingham Masters , President Global Sales Ross Portaro , and 10 percent owner Masters Special Situations, Llc .

Venus Concept Inc (VERO) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Venus Concept Inc (VERO). Other recent insider transactions involving Venus Concept Inc (VERO) include a net sale of 958,979 shares made by Michael Willingham Masters ,

In summary, during the past 3 months, insiders sold 469,031 shares of Venus Concept Inc (VERO) in total and bought 0 shares, with a net sale of 469,031 shares. During the past 18 months, 958,979 shares of Venus Concept Inc (VERO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 958,979 shares.

Venus Concept Inc (VERO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Venus Concept Inc Insider Transactions

No Available Data

What does Obalon Therapeutics Inc do?

Who are the key executives at Obalon Therapeutics Inc?

Arnold L Oronsky is the 10 percent owner of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .

Obalon Therapeutics Inc (OBLN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Obalon Therapeutics Inc Insider Transactions

No Available Data

What does Eiger BioPharmaceuticals Inc do?

Who are the key executives at Eiger BioPharmaceuticals Inc?

Arnold L Oronsky is the 10 percent owner of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .

Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .

In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.

Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eiger BioPharmaceuticals Inc Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Arnold L Oronsky is the director of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Applied Genetic Technologies Corp do?

Who are the key executives at Applied Genetic Technologies Corp?

Arnold L Oronsky is the director of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .

Applied Genetic Technologies Corp (AGTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Applied Genetic Technologies Corp Insider Transactions

No Available Data

What does Glaukos Corp do?

Who are the key executives at Glaukos Corp?

Arnold L Oronsky is the 10 percent owner of Glaukos Corp. Other key executives at Glaukos Corp include CFO & SVP Corporate Development Joseph E Gilliam , SVP & Chief Financial Officer Alex R. Thurman , and director & 10 percent owner & Chief Executive Officer Thomas William Burns .

Glaukos Corp (GKOS) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 311,429 shares made by Joseph E Gilliam , a net sale of 520,000 shares made by Thomas William Burns , and a net sale of 6,762 shares made by Alex R. Thurman .

In summary, during the past 3 months, insiders sold 41,525 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 41,525 shares. During the past 18 months, 942,098 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 942,098 shares.

Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glaukos Corp Insider Transactions

No Available Data

What does Invuity Inc do?

Who are the key executives at Invuity Inc?

Arnold L Oronsky is the 10 percent owner of Invuity Inc. Other key executives at Invuity Inc include Chief Financial Officer James H Mackaness , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .

Invuity Inc (IVTY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Invuity Inc Insider Transactions

No Available Data

What does Marketo Inc do?

Who are the key executives at Marketo Inc?

Arnold L Oronsky is the 10 percent owner of Marketo Inc. Other key executives at Marketo Inc include SVP & Chief Financial Officer Brian K Kinion , EVP Worldwide Field Operations Steven M Winter , and SVP & GC & Secretary Margo Smith .

Marketo Inc (MKTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marketo Inc (MKTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marketo Inc (MKTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marketo Inc (MKTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marketo Inc Insider Transactions

No Available Data

What does Macrogenics Inc do?

Who are the key executives at Macrogenics Inc?

Arnold L Oronsky is the director & 10 percent owner of Macrogenics Inc. Other key executives at Macrogenics Inc include Acting General Counsel Jeffrey Stuart Peters , SVP & CFO and Secretary James Karrels , and Sr VP & BPD & Manufacturing Thomas Spitznagel .

Macrogenics Inc (MGNX) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Macrogenics Inc (MGNX). Other recent insider transactions involving Macrogenics Inc (MGNX) include a net sale of 163,395 shares made by Jeffrey Stuart Peters , a net sale of 48,846 shares made by Ezio Bonvini , and a net purchase of 350,000 shares made by Biotech Target N V .

In summary, during the past 3 months, insiders sold 0 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 293,400 shares of Macrogenics Inc (MGNX) were sold and 365,000 shares were bought by its insiders, resulting in a net purchase of 71,600 shares.

Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Macrogenics Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Arnold L Oronsky is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Metabasis Therapeutics Inc do?

Who are the key executives at Metabasis Therapeutics Inc?

Arnold L Oronsky is the director of Metabasis Therapeutics Inc. Other key executives at Metabasis Therapeutics Inc include 10 percent owner Mpm Asset Management Investors 2000b Llc , 10 percent owner Mpm Asset Management Ii Llc , and 10 percent owner Mpm Asset Management Ii Lp .

Metabasis Therapeutics Inc (LGNZZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metabasis Therapeutics Inc (LGNZZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metabasis Therapeutics Inc (LGNZZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metabasis Therapeutics Inc (LGNZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metabasis Therapeutics Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Arnold L Oronsky is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

What does Reshape Lifesciences Inc do?

Who are the key executives at Reshape Lifesciences Inc?

Arnold L Oronsky is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , director & President and CEO Paul F. Hickey , and 10 percent owner Armistice Capital, Llc .

Reshape Lifesciences Inc (RSLS) Insider Trades Summary

Over the past 18 months, Arnold L Oronsky made no insider transaction in Reshape Lifesciences Inc (RSLS). Other recent insider transactions involving Reshape Lifesciences Inc (RSLS) include a net purchase of 16,686 shares made by Thomas Stankovich ,

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18 shares of Reshape Lifesciences Inc (RSLS) were sold and 305 shares were bought by its insiders, resulting in a net purchase of 288 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reshape Lifesciences Inc Insider Transactions

No Available Data

Arnold L Oronsky Mailing Address

Above is the net worth, insider trading, and ownership report for Arnold L Oronsky. You might contact Arnold L Oronsky via mailing address: C/o Interwest Partners, 467 First Street Suite 201, Los Altos Ca 94022.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.